Last reviewed · How we verify

Quinidine Gluconate — Competitive Intelligence Brief

Quinidine Gluconate (QUINIDINE SULFATE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiarrhythmic. Area: Neuroscience.

marketed Antiarrhythmic Muscarinic acetylcholine receptor M2 Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Quinidine Gluconate (QUINIDINE SULFATE) — Eli Lilly. Quinidine Gluconate works by blocking the M2 muscarinic acetylcholine receptor, which helps regulate heart rhythm.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Quinidine Gluconate TARGET QUINIDINE SULFATE Eli Lilly marketed Antiarrhythmic Muscarinic acetylcholine receptor M2 1950-01-01
Toviaz Fesoterodine Fumarate Pfizer marketed fesoterodine Muscarinic acetylcholine receptor M2 2008-01-01
Toviaz FESOTERODINE Pfizer marketed fesoterodine Muscarinic acetylcholine receptor M2 2008-01-01
HEXOCYCLIUM HEXOCYCLIUM AbbVie marketed hexocyclium Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3 1982-01-01
Syncurine DECAMETHONIUM marketed decamethonium Acetylcholinesterase, Histamine H3 receptor, Muscarinic acetylcholine receptor M2 1975-01-01
Cantil MEPENZOLATE Sanofi marketed Anticholinergic Muscarinic acetylcholine receptor M2 1956-01-01
Kemadrine PROCYCLIDINE marketed Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3 1955-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiarrhythmic class)

  1. Pfizer · 3 drugs in this class
  2. National Taiwan University Hospital · 2 drugs in this class
  3. Boehringer Ingelheim · 1 drug in this class
  4. Cliniques universitaires Saint-Luc- Université Catholique de Louvain · 1 drug in this class
  5. Eli Lilly · 1 drug in this class
  6. MTI Medical Private Limited, Pakistan · 1 drug in this class
  7. Technical University of Munich · 1 drug in this class
  8. · 1 drug in this class
  9. Wyeth is now a wholly owned subsidiary of Pfizer · 1 drug in this class
  10. Ain Shams University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Quinidine Gluconate — Competitive Intelligence Brief. https://druglandscape.com/ci/quinidine-sulfate. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: